Dirigido a Médicos, Personal de Enfermería, Tecnólogas y Navegador@s de cáncer

SPONSORSHIP STATEMENT 

This activity is sponsored by The Ponce Medical School Foundation, Inc. and the “Sociedad Puertorriqueña de Senología”.   

 ACCREDITATION STATEMENT 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Ponce Medical School Foundation, Inc., and “Sociedad Puertorriqueña de Senología”. The Ponce Medical School Foundation, Inc is accredited by the Accreditation Council for Continuing Medical Education (ACCME), Provider’s No. 0007249, to provide continuing medical education for physicians. The Ponce Medical School Foundation, Inc is accredited by the Puerto Rico Board of Licensing and Medical Disciplines, provider’s No. 016-DC23-JLDM.  

CREDIT DESIGNATION 

The Ponce Medical School Foundation, Inc designate this educational activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

FACULTY DISCLOSURE POLICY 

It is the policy of Ponce Medical School Foundation, Inc to ensure independence, balance, objectivity, scientific rigor and integrity in all of its sponsored educational activities. 

All persons who are in a position to control the educational content of a sponsored activity are expected to disclose to the participants any relevant financial relationship(s) they have with the commercial supporters and/or providers of commercial services and/or manufacturers of any commercial products discussed during the educational activity. All conflicts of interest have been identified and resolved prior to the release of this activity.  

 TARGET AUDIENCE 

This program is designed for physicians.

NEED ASSESMENT

The World Health Organization: 

There are more than 2.3 million cases of breast cancer that occur each year, which make it the most common cancer among adults. In 95% of countries, breast cancer is the first or second leading cause of female cancer deaths.  

 The American Cancer Society: 

In the US in 2022, an estimated 287,850 new cases of invasive breast cancer will be diagnosed among women and 43,250 women will die from the disease.  In addition, an estimated 51,400 cases of DCIS will be diagnosed among women. Although breast cancer is predominantly a female disease, approximately 2,710 new cases and 530 deaths (about 1% of all breast cancer cases and deaths) will occur among men.  

Breast Cancer in PUERTO RICO 

Puerto Rico Health Department Cancer Registry: 

In Puerto Rico, during the period 2014-2018, breast cancer accounted for 28.9% of all cancer cases in women and 18.9% of all cancer deaths in women.   

On average, 2,242 women were diagnosed annually with invasive breast cancer.  

On average, 437 women died each year from breast cancer.  

1 in 9 women born today in Puerto Rico could be diagnosed with breast cancer during their lifetime.  

For cases diagnosed between 2010 and 2014, the relative 5-year survival of breast cancer in women was 86.2%.  

REFERENCE: 

World Health Organization, Breast Cancer: Prevention and Control – www.who.int/cancer/detection/breastcancer 

American Cancer Society, Breast Cancer Facts & Figures – www.cancer.org 

Puerto Rico Health Cancer Registry, Cancer in Puerto Rico – http://rcpr.org/Publicaciones/Reportes-Anuales 

LEARNING OBJECTIVES 

1. Promote scientific exchange among all the professionals involved in the diagnosis, treatment, and rehabilitation of the patient with breast cancer.
2. Define scientifically proved current management of breast cancer.
3. Present the latest advances in this field.
4. Define the role of the various members of the medical team in the management of breast cancer patient; this includes latest information in basic science, diagnostic tools, therapeutic methods, and rehabilitation aspects in breast cancer